Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine

MLA

Iftak Hussain, et al. “Recurrence Monitoring for Ovarian Cancer Using a Cell Phone-Integrated Paper Device to Measure the Ovarian Cancer Biomarker HE4/CRE Ratio in Urine.” Scientific Reports, vol. 11, no. 1, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....884d256681d11e7d94431af85006cae5&authtype=sso&custid=ns315887.

APA

Iftak Hussain, Frederick R. Haselton, Audrey K. Bowden, & Emily C Kight. (2021). Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine. Scientific Reports, 11(1).

Chicago

Iftak Hussain, Frederick R. Haselton, Audrey K. Bowden, and Emily C Kight. 2021. “Recurrence Monitoring for Ovarian Cancer Using a Cell Phone-Integrated Paper Device to Measure the Ovarian Cancer Biomarker HE4/CRE Ratio in Urine.” Scientific Reports 11 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....884d256681d11e7d94431af85006cae5&authtype=sso&custid=ns315887.